Navigation Links
Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
Date:4/27/2008

he Second University of Naples, an institution with long-standing experience in collecting and studying patients with inherited retinal diseases, under the supervision of Francesca Simonelli, M.D.

Testing continued over a period of six months following the gene therapy vector administration. One patient was better able to navigate an obstacle course compared to before the injection. The patients also had less nystagmus, an involuntary movement of the eyes that is common in LCA. In the patient who experienced better vision even in the uninjected eye, the researchers suggest that the reduced nystagmus benefited both eyes.

"The current clinical trial will continue with more patients and with ongoing follow-up to monitor results," said Bennett. "We expect improvements to be more pronounced if treatment occurs in childhood, before the disease progresses."

"This result is important for the entire field of gene therapy," notes High, a past president of the American Society of Gene Therapy. "Gene transfer has been in clinical trials for over 15 years now, and although it has an excellent safety record, examples of therapeutic effect are still relatively few. The results in this study provide objective evidence of improvement in the ability to perceive light, and thus lay the groundwork for future studies in this and other retinal disorders," said High.

The pace of moving from pre-clinical discoveries into clinical trials has typically been slow in the field of gene therapy due to the breadth of expertise required, ranging from in-depth knowledge of the disorder to detailed understanding of vector design, manufacture, and pre-clinical evaluation. The complexities of regulatory oversight at both the federal and local levels also present challenges. Through the Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia has developed concentrated expertise and substantial resources to facilitate the "bench to beds
'/>"/>

SOURCE The Children's Hospital of Philadelphia; University ofPennsylvania
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Gene Therapy Provides Vision to People who Were Nearly Blind
2. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
3. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
4. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
5. Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells
6. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
7. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
8. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
9. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
10. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
11. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Kepner-Tregoe (KT), the global capability development ... Chris Geraghty has been ... than 20 years serving the industrial sector, holding ... succeeds Ray Baxter , who ... the Board and CEO. (Logo: ...
(Date:5/21/2013)... N.J. , May 21, 2013  Armada ... launch of the new Armada corporate website ( ... clearly communicate Armada,s unique and first-to-market services and ... company focused on the specialty pharmacy industry. ... expansion of the Armada business model in delivering ...
(Date:5/21/2013)... N.J. , May 21, 2013 Hurel ... constructs and microfluidic cell-based assay platforms, today announced the ... PhD, DABT to the Company,s Board of Directors. Dr. ... Development of the Schering-Plough Research Institute ("SPRI"), which was ... its acquisition by Merck & Co. in 2009. ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... , Physicians and patient to share ... Sept. 21 Representatives from the Kennedy Krieger Institute will take part ... September 21 in Baltimore, Md., joining more than 1,200 of the world,s ... following: , , Concurrent Session , ...
... , THOUSAND OAKS, Calif., Sept. 21 ... results from a Phase 3 trial evaluating denosumab administered subcutaneously ... the treatment of bone metastases in 1,776 advanced cancer patients ... multiple myeloma. These results were presented today at the ...
Cached Medicine Technology:Kennedy Krieger Institute to Participate in 2009 World Stem Cell Summit 2Kennedy Krieger Institute to Participate in 2009 World Stem Cell Summit 3Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 2Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 3Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 4Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 6Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 7Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 8Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 9
(Date:5/21/2013)... BOSTON (May 21, 2013) Prostaglandin analogues (PGAs), drugs ... of treatment for people with glaucoma, but their use ... with blurred vision, dryness, changes in eye color and ... that these drugs also cause upper and lower eyelid ... The findings are described in PLOS ONE . ...
(Date:5/21/2013)... HealthSmart continues to grow through strategic acquisitions ... the hiring of new talent in several areas, including ... that Dawn Powell has joined the organization effective April ... Account Management in the Central Region and is based ... extensive client management, employee benefits, and product development experience, ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Arizona ... inventors who want to develop their ideas into ... program. , The university is recruiting participants ... new “formation space” that provides early-stage entrepreneurs with ... AREA48 is open to anyone, ASU is particularly ...
(Date:5/21/2013)... 2013 Phoseon Technology will present their ... 20th Annual IMI European Ink Jet Conference (June ... Phoseon continues to invest in product development to enable ... UV LED curing in printing applications. Phoseon currently ... market offering both air cooled and water cooled solutions ...
(Date:5/21/2013)... Texas (PRWEB) May 21, 2013 ... With the help of Texas Counseling’s Sexuality and ... communication, and the development of healthier habits for ... workshops available for both couples and individuals at ... enhance their relationships and learn skills to develop ...
Breaking Medicine News(10 mins):Health News:Glaucoma drug can cause droopy eyelids 2Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2
... cancer have a slightly better long-term side effects profile ... to a study.// ,Doctors in France conducted ... stage prostate cancer to evaluate a man’s quality of ... based on the type of treatment the patient received: ...
... patients looking for organ transplantation.// ,Although Japanese ... in Chinese hospitals, more people, frustrated with years of ... in their homeland are turning to the neighbouring nation ... ,Kenichi Hokamura, 63, of the southern Japanese province of ...
... by Finance minister P.Chidambaram has drawn cheers from some quarters ... 'The education and health sectors will also receive substantial funds. ... by 34.2 per cent to Rs.32,352 crore and for health ... ,Dissuading smoking has been a ...
... account for 70 percent of accidental deaths in persons 75 ... beginning of the end. But in a new study, researchers// ... Falls and hip fractures don’t have to be inevitable, the ... of Biofeedback. ,Hip fractures, more than 300,000 per ...
... is an auspicious day for all Hindus. It is ... good over evil. This festival has been celebrated for// ... to participate and remember our past has not changed. ... economization a lot has changed. Substandard quality products populate ...
... and rapidly growing teens are likely to find themselves ... life, suggests// research in the Journal of Epidemiology and ... the age of 15 boosted cholesterol levels, the study ... 3000 participants of a Medical Research Council long term ...
Cached Medicine News:Health News:Prostate Brachytherapy Causes Fewer Side Effects Than Surgery 2Health News:Union Budget: Impact on Health Sector 2Health News:Union Budget: Impact on Health Sector 3Health News:Chemicals Used To Make Synthetic Color Can Cause Cancer And Permanent Blindness 2
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details...
Medicine Products: